Broadwing Bio

Broadwing Bio is advancing antibody therapies to treat ophthalmic diseases. With a strong portfolio of antibody drugs and genetically validated targets, we aim to address unmet needs in the ophthalmology field and fundamentally transform people's lives. The Broadwing team possesses deep expertise in antibody discovery and development. We leverage Alloy Therapeutic’s industry-leading capabilities to generate antibodies and develop therapies focused on maximizing potential benefits for both patients and providers.